Company Valuation: Collegium Pharmaceutical, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 650 778.9 1,004 924 1,464 1,170 - -
Change - 19.82% 28.87% -7.95% 58.4% -20.05% - -
Enterprise Value (EV) 1 650 778.9 1,004 924 1,464 1,921 1,498 1,170
Change - 19.82% 28.87% -7.95% 58.4% 31.26% -22.03% -21.88%
P/E 10x -31.4x 23.9x 15.4x 26.8x 13.6x 9.67x -
PBR - - - - - 3.3x 2.33x -
PEG - 0x -0x 0.3x -3.83x 0.3x 0.2x -
Capitalization / Revenue 2.35x 1.68x 1.77x 1.46x 1.88x 1.34x 1.35x 1.4x
EV / Revenue 2.35x 1.68x 1.77x 1.46x 1.88x 2.2x 1.73x 1.4x
EV / EBITDA 5.49x 2.93x 2.74x 2.3x 3.18x 3.96x 3.41x 3.23x
EV / EBIT 36.9x 23.4x 6.01x 5.44x 8.15x 4.05x 3.45x 3x
EV / FCF - - 3.66x 4.54x 4.47x 6.1x 3.56x -
FCF Yield - - 27.3% 22% 22.4% 16.4% 28.1% -
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 1.86 -0.74 1.29 1.86 1.73 2.66 3.73 -
Distribution rate - - - - - - - -
Net sales 1 276.9 463.9 566.8 631.4 780.6 872.9 866 833.9
EBITDA 1 118.3 266 367 401.2 460.5 484.5 438.6 362.7
EBIT 1 17.63 33.32 167 169.9 179.6 474.5 434.5 389.7
Net income 1 71.52 -25 48.16 69.19 62.87 108.2 158.3 -
Net Debt 1 - - - - - 750.9 327.7 -
Reference price 2 18.68 23.20 30.78 28.65 46.30 36.08 36.08 36.08
Nbr of stocks (in thousands) 34,797 33,572 32,611 32,250 31,611 32,434 - -
Announcement Date 24/02/22 23/02/23 22/02/24 27/02/25 26/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
13.64x2.21x3.98x - 1.18B
34.75x12.42x25.87x0.58% 1,043B
26.86x6.13x16.78x2.15% 602B
33.14x7.52x15.43x2.7% 449B
17.71x4.39x10.82x3.02% 327B
21.31x5.47x13.24x2.89% 279B
21.26x4.48x12.39x1.96% 264B
24.37x6.42x11.35x2.71% 201B
-49.1x5.86x32.41x2.38% 169B
12.77x3.12x7.88x6.86% 143B
Average 15.67x 5.80x 15.02x 2.81% 347.82B
Weighted average by Cap. 23.88x 7.73x 18.23x 2.11%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. COLL Stock
  4. Valuation Collegium Pharmaceutical, Inc.